Longitudinal Trajectory Modeling to Assess Adherence to Sacubitril/Valsartan Among Patients With Heart Failure
Source : https://www.mdpi.com/1999-4923/15/11/2568
Medication adherence in chronic conditions is a long-term process. Modeling longitudinal trajectories using routinely collected prescription data is a promising method for describing adherence patterns and identifying at-risk groups. The...
The central finding of this study underscores that <50% of patients with HF prescribed sacubitril/valsartan maintain high medication adherence within 1 year from the initial prescription.
Predictive Value of the Hemoglobin-Geriatric Nutritional Risk Index in Patients With Heart Failure
Source : https://www.mdpi.com/2072-6643/15/22/4789
Malnutrition prevails among patients with heart failure (HF), increasing the likelihood of functional decline. We assessed the predictive value of the Hemoglobin-Geriatric Nutritional Risk Index (H-GNRI)-combining hemoglobin and the Geriatric...
Researchers found that the H-GNRI score was associated with BI at discharge, BI gain, BI efficiency, length of hospital stay, in-hospital mortality, discharge to home or a nursing home, and hospitalization-associated disability.
Insights Into the Interaction of Heart Failure With Preserved Ejection Fraction and Sleep-Disordered Breathing
Source : https://www.mdpi.com/2227-9059/11/11/3038
Heart failure with preserved ejection fraction (HFpEF) is emerging as a widespread disease with global socioeconomic impact. Patients with HFpEF show a dramatically increased morbidity and mortality, and, unfortunately, specific...
Sleep-disordered breathing and HFpEF are often closely interwoven, and there might even be bidirectional associations that promote a vicious circle.
Health-Related Quality of Life in Patients With Ventricular Assist Device: Psychometric Evaluation of the German Version of the Quality of Life With a Ventricular Assist Device Questionnaire
In a multicenter, cross-sectional study, 393 participants (mean age, 58.3 years; 85.8% male, 60.3% bridge to transplant, and 72.8% living with VAD for ≤2 years) completed the German Quality of...
The implantation of ventricular assist devices (VADs) has emerged as an alternative treatment strategy for the growing number of patients with end-stage heart failure.
Effects of Semaglutide on Symptoms, Function, and Quality of Life in Patients With Heart Failure With Preserved Ejection Fraction and Obesity: a Prespecified Analysis of the STEP-HFpEF Trial
Source : https://pubmed.ncbi.nlm.nih.gov/37952180/
Patients with heart failure (HF) with preserved ejection fraction (HFpEF) and obesity experience high burden of symptoms and functional impairment, and a poor quality of life.